Harmony Biosciences Holdings Target Price

See Harmony Biosciences Holdings's analyst price targets ($47) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$41.26

Average Target Price

$46.71

13.2% upside

7 analysts in the last 4 months

High: $70 | Low: $34

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-26	Wolfe ResearchRudy Li	$60	45.4% upside
2026-08-05	Deutsche Bank	$39	5.5% downside
2026-08-05	Truist FinancialDanielle Brill	$34	17.6% downside
2026-08-05	UBS	$37	10.3% downside
2026-08-04	OppenheimerAndreas Argyrides	$70	69.7% upside
2026-08-03	Mizuho Securities	$51	23.6% upside
2026-06-30	Deutsche BankDavid Hoang	$36	12.7% downside
2026-02-23	Deutsche Bank	$31	24.9% downside
2026-02-19	Mizuho Securities	$50	21.2% upside
2026-02-11	UBSYoun Shim	$46	11.5% upside
2026-01-08	Truist Financial	$45	9.1% upside
2025-12-01	Mizuho Securities	$46	11.5% upside
2025-11-24	OppenheimerAndreas Argyrides	$62	50.3% upside
2025-10-29	Mizuho Securities	$36	12.7% downside
2025-10-15	UBS	$43	4.2% upside
2025-09-25	H.C. Wainwright	$55	33.3% upside
2025-07-10	Goldman SachsCorinne Johnson	$33	20% downside
2025-04-28	UBS	$48	16.3% upside
2024-10-30	Goldman SachsCorinne Jenkins	$28	32.1% downside
2024-10-10	Mizuho SecuritiesGraig Suvannavejh	$52	26% upside
2024-09-10	UBSAshwani Verma	$56	35.7% upside
2024-08-08	Mizuho SecuritiesGraig Suvannavejh	$42	1.8% upside
2024-06-24	OppenheimerFrancois Brisebois	$56	35.7% upside
2024-05-01	NeedhamAmi Fadia	$52	26% upside
2024-04-30	Raymond JamesDanielle Brill	$37	10.3% downside
2022-10-14	JefferiesChris Howerton	$61	47.8% upside

Harmony Biosciences Holdings (HRMY) FAQ

As of the most recent data, HRMY shows a target price of $47. Scroll down for historical charts and peer comparison views.

If Harmony Biosciences Holdings moved to the average analyst target of $47, shares would be roughly 13.2% higher than $41.26. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Harmony Biosciences Holdings's earnings trajectory.

Besides this target price page, Stockcircle has Harmony Biosciences Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $47) with ownership activity and broader fundamentals.

Harmony Biosciences Holdings's target price is $47; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.